The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
source: pixabay.com

The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic

 The United States FDA has just announced that they will be providing  6 new grants, which are worth 16 million dollars for rare disease research. These grants will last a…

Continue Reading The FDA Has Provided 16 Million Dollars to Scientists to Continue Rare Disease Research During the Pandemic
Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment
source: pixabay.com

Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment

According to a story from BioSpace, the biotechnology company Tiziana Life Sciences plc has announced that it was recently granted a patent from the United States Patent and Trademark Office…

Continue Reading Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment
Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
source: pixabay.com

Scientists Screen for Pancreatic Cancer Using Artificial Intelligence

  News-Medical Life Sciences recently interviewed Dr. Ananya Malhotra, Research Fellow at the London School of Hygiene, regarding her most current research involving pancreatic cancer. Dr. Malhotra believes artificial intelligence (AI)…

Continue Reading Scientists Screen for Pancreatic Cancer Using Artificial Intelligence
ICYMI: SM-88 Receives Orphan Drug Designation as Pancreatic Cancer Treatment
mohamed_hassan / Pixabay

ICYMI: SM-88 Receives Orphan Drug Designation as Pancreatic Cancer Treatment

  Earlier this week, biotechnology company Time Technologies announced that its drug candidate SM-88 received Orphan Drug Designation from the FDA for the treatment of pancreatic cancer. The FDA defines…

Continue Reading ICYMI: SM-88 Receives Orphan Drug Designation as Pancreatic Cancer Treatment

Editor’s Choice: Stevens-Johnson Syndrome Awareness Month

Happy Friday! Did you know that August is Stevens-Johnson Syndrome Awareness Month? It's a type of severe skin reaction that often involves admission to a burn unit for treatment. We've…

Continue Reading Editor’s Choice: Stevens-Johnson Syndrome Awareness Month
A Possible Treatment for Pancreatic Cancer Just Earned Orphan Drug Designation
source: pixabay.com

A Possible Treatment for Pancreatic Cancer Just Earned Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Tyme, Inc. has just announced that it has earned Orphan Drug designation for its experimental product candidate SM-88. SM-88, also known…

Continue Reading A Possible Treatment for Pancreatic Cancer Just Earned Orphan Drug Designation
Treating Pancreatic Cancer with Cysteinase: A Potential New Approach
mohamed_hassan / Pixabay

Treating Pancreatic Cancer with Cysteinase: A Potential New Approach

According to a news release, researchers have found that cysteinase, a compound designed to treat a rare kidney stone disease, may also be effective in treating patients with pancreatic cancer.…

Continue Reading Treating Pancreatic Cancer with Cysteinase: A Potential New Approach
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 
source: pixabay.com

ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 

  Cell-in-a-Box, the name of one of Biotech’s new products is just as intriguing as the drug itself. A recent article in NewsFile characterizes the product as having the potential…

Continue Reading ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 
Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
source: pixabay.com

Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?

According to a story from Newsfile, the biotechnology company PharmaCyte is beginning to turn heads with the potential of its proprietary Cell-in-a-Box technology that has the potential to greatly improve…

Continue Reading Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
source: pixabay.com

Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“

  The ASCO Post recently reported findings of high response rates and improved survival from the combination of platinum-based cisplatin and gemcitabine (chemotherapy) in BRCA/PALB2 mutation positive pancreatic ductal adenocarcinoma. The goal…

Continue Reading Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
source: pixabay.com

2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza

  According to an article in BioSpace, the FDA recently approved the PARP inhibitor Lynparza that was developed by Merck and AstraZeneca to be used as maintenance therapy for pancreatic…

Continue Reading 2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments
https://pixabay.com/en/notebook-work-girl-computer-woman-2386034/

PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments

According to a press release from Mateon Therapeutics, Mateon's recent merger agreement with PointR Data establishes plans to combine the use of artificial intelligence and data collection for the development…

Continue Reading PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments
Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation
source: pixabay.com

Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation

According to a story from BioSpace, the biopharmaceutical company CrystalGenomics, Inc. recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational drug candidate CG-745 Orphan…

Continue Reading Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation
Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer
Republica / Pixabay

Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer

According to a story from Medpage Today, a recent, small scale, early study of patients with local but advanced pancreatic cancer revealed that an experimental combination treatment comprised of chemoradiation…

Continue Reading Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer
Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
mohamed_hassan / Pixabay

Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia

According to a publication from EurekAlert, researchers from the University of Oklahoma College of Medicine (OUCM) recently published a study in the journal Gastroenterology suggesting how cachexia is triggered in…

Continue Reading Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
stevepb / Pixabay

Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

According to a publication from the Arizona BioIndustry Association, Dr. Rachna Shroff and a team of researchers from the Arizona Cancer Center are studying the use of nab-paclitaxel (a pancreatic…

Continue Reading Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

A Blood Test That Can Detect Seven Types of Cancer

  Health News Digest recently published an article that describes a simple blood test called DELFI, meaning DNA evaluation of fragments for early interception. Its simplicity belies the fact that it can detect…

Continue Reading A Blood Test That Can Detect Seven Types of Cancer
Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
Close Menu